SP

Steve Paul

Founder and Board Chair at Seaport Therapeutics and Venture Partner at Third Rock Ventures

United States

Investor
VC
Angel

Invests in

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Research
Teaching
Biotechnology
Strategic Planning
Lifesciences
Clinical Research
Genetics

Education

Lists including Steve

AT
AS
AT
AH

All Series A Investors

14748 people

AT
AE
AE
AL

All Pre-Seed Investors

7972 people

Investments

Rapport Therapeutics

Series A

Total Funding: $250M

Karuna Therapeutics

Series A

Total Funding: $110M

SAGE Therapeutics

Series C

Total Funding: $58M

Voyager Therapeutics

Series A

Total Funding: $45M

Work Experience

ST
Seaport Therapeutics

2024

  • Founder and Board Chair

    2024

TR
Third Rock Ventures

2010

  • Venture Partner

    2010

KT
Karuna Therapeutics

2018 - 2024

  • President of Research & Development and Chief Scientific Officer

    2023 - 2024

  • CEO and Chairman of the Board

    2018 - 2023

VT
Voyager Therapeutics, Inc.

2018 - 2022

  • Senior Advisor, Co-founder and Board Member

    2018 - 2022

VT
Voyager Therapeutics, Inc.

2014 - 2018

  • CEO

    2014 - 2018